Annual Operating Profit:
$4.09B-$141.50M(-3.34%)Summary
- As of today, REGN annual operating income is $4.09 billion, with the most recent change of -$141.50 million (-3.34%) on December 31, 2024.
- During the last 3 years, REGN annual operating profit has fallen by -$4.90 billion (-54.51%).
- REGN annual operating profit is now -54.51% below its all-time high of $8.99 billion, reached on December 31, 2021.
Performance
REGN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
$1.11B+$20.40M(+1.87%)Summary
- As of today, REGN quarterly operating income is $1.11 billion, with the most recent change of +$20.40 million (+1.87%) on September 30, 2025.
- Over the past year, REGN quarterly operating profit has dropped by -$125.80 million (-10.18%).
- REGN quarterly operating profit is now -66.84% below its all-time high of $3.35 billion, reached on June 30, 2021.
Performance
REGN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
$3.83B-$125.80M(-3.18%)Summary
- As of today, REGN TTM operating income is $3.83 billion, with the most recent change of -$125.80 million (-3.18%) on September 30, 2025.
- Over the past year, REGN TTM operating profit has dropped by -$308.40 million (-7.45%).
- REGN TTM operating profit is now -58.01% below its all-time high of $9.12 billion, reached on March 31, 2022.
Performance
REGN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
REGN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -3.3% | -10.2% | -7.5% |
| 3Y3 Years | -54.5% | -9.3% | -40.7% |
| 5Y5 Years | +85.2% | +5.4% | +24.1% |
REGN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -54.5% | at low | -15.6% | +83.8% | -40.7% | at low |
| 5Y | 5-Year | -54.5% | +85.2% | -66.8% | +83.8% | -58.0% | +24.1% |
| All-Time | All-Time | -54.5% | +2094.4% | -66.8% | +1940.0% | -58.0% | +1966.8% |
REGN Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.11B(+1.9%) | $3.83B(-3.2%) |
| Jun 2025 | - | $1.09B(+80.4%) | $3.96B(-0.1%) |
| Mar 2025 | - | $604.00M(-41.2%) | $3.96B(-3.8%) |
| Dec 2024 | $4.09B(-3.3%) | $1.03B(-16.9%) | $4.11B(-0.6%) |
| Sep 2024 | - | $1.24B(+13.0%) | $4.14B(+0.6%) |
| Jun 2024 | - | $1.09B(+44.2%) | $4.11B(+1.9%) |
| Mar 2024 | - | $758.50M(-27.8%) | $4.04B(-5.7%) |
| Dec 2023 | $4.23B(-15.2%) | $1.05B(-13.2%) | $4.28B(-5.8%) |
| Sep 2023 | - | $1.21B(+19.1%) | $4.55B(-0.3%) |
| Jun 2023 | - | $1.02B(+1.4%) | $4.56B(-6.0%) |
| Mar 2023 | - | $1.00B(-23.8%) | $4.85B(-5.5%) |
| Dec 2022 | $4.99B(-44.5%) | $1.32B(+7.5%) | $5.13B(-20.5%) |
| Sep 2022 | - | $1.22B(-6.4%) | $6.46B(-8.8%) |
| Jun 2022 | - | $1.31B(+1.6%) | $7.08B(-22.4%) |
| Mar 2022 | - | $1.29B(-51.3%) | $9.12B(+1.9%) |
| Dec 2021 | $8.99B(+151.5%) | $2.64B(+42.9%) | $8.95B(+19.7%) |
| Sep 2021 | - | $1.85B(-44.8%) | $7.47B(+11.9%) |
| Jun 2021 | - | $3.35B(+200.8%) | $6.68B(+67.5%) |
| Mar 2021 | - | $1.11B(-4.7%) | $3.99B(+11.5%) |
| Dec 2020 | $3.58B(+61.9%) | $1.17B(+10.8%) | $3.58B(+15.9%) |
| Sep 2020 | - | $1.05B(+60.4%) | $3.09B(+11.4%) |
| Jun 2020 | - | $656.40M(-6.2%) | $2.77B(+14.0%) |
| Mar 2020 | - | $700.10M(+3.6%) | $2.43B(+10.0%) |
| Dec 2019 | $2.21B(-12.8%) | $675.70M(-8.5%) | $2.21B(-1.9%) |
| Sep 2019 | - | $738.50M(+134.0%) | $2.25B(+5.2%) |
| Jun 2019 | - | $315.60M(-34.3%) | $2.14B(-12.5%) |
| Mar 2019 | - | $480.00M(-33.2%) | $2.45B(-3.4%) |
| Dec 2018 | $2.53B(+21.9%) | $718.10M(+14.5%) | $2.53B(+7.6%) |
| Sep 2018 | - | $626.92M(+0.8%) | $2.36B(+2.9%) |
| Jun 2018 | - | $622.19M(+9.7%) | $2.29B(+3.2%) |
| Mar 2018 | - | $567.23M(+5.3%) | $2.22B(+6.6%) |
| Dec 2017 | $2.08B(+56.3%) | $538.81M(-3.8%) | $2.08B(+10.2%) |
| Sep 2017 | - | $559.93M(+1.7%) | $1.89B(+11.7%) |
| Jun 2017 | - | $550.31M(+27.8%) | $1.69B(+18.1%) |
| Mar 2017 | - | $430.54M(+24.1%) | $1.43B(+7.6%) |
| Dec 2016 | $1.33B(+6.3%) | $347.00M(-4.4%) | $1.33B(+9.5%) |
| Sep 2016 | - | $362.80M(+24.4%) | $1.21B(-2.4%) |
| Jun 2016 | - | $291.63M(-11.4%) | $1.24B(-4.1%) |
| Mar 2016 | - | $329.31M(+42.5%) | $1.30B(+3.7%) |
| Dec 2015 | $1.25B(+51.9%) | $231.08M(-41.1%) | $1.25B(-1.3%) |
| Sep 2015 | - | $392.42M(+13.8%) | $1.27B(+19.8%) |
| Jun 2015 | - | $344.86M(+21.6%) | $1.06B(+13.1%) |
| Mar 2015 | - | $283.55M(+14.6%) | $936.04M(+11.6%) |
| Dec 2014 | $823.92M(+10.9%) | $247.37M(+35.4%) | $838.43M(+4.4%) |
| Sep 2014 | - | $182.72M(-17.8%) | $803.14M(-6.3%) |
| Jun 2014 | - | $222.41M(+19.6%) | $857.22M(+8.1%) |
| Mar 2014 | - | $185.94M(-12.3%) | $792.92M(+4.3%) |
| Dec 2013 | $743.05M(+62.3%) | $212.07M(-10.4%) | $760.03M(+9.6%) |
| Sep 2013 | - | $236.80M(+49.8%) | $693.73M(+5.0%) |
| Jun 2013 | - | $158.10M(+3.3%) | $660.49M(+11.7%) |
| Mar 2013 | - | $153.05M(+5.0%) | $591.36M(+28.4%) |
| Dec 2012 | $457.71M(+323.1%) | $145.77M(-28.4%) | $460.51M(+71.0%) |
| Sep 2012 | - | $203.56M(+128.8%) | $269.34M(+3579.5%) |
| Jun 2012 | - | $88.98M(+300.8%) | $7.32M(+105.2%) |
| Mar 2012 | - | $22.20M(+148.9%) | -$141.98M(+30.8%) |
| Dec 2011 | -$205.16M(-110.5%) | -$45.40M(+22.3%) | -$205.16M(-18.9%) |
| Sep 2011 | - | -$58.46M(+3.1%) | -$172.53M(-18.0%) |
| Jun 2011 | - | -$60.32M(-47.2%) | -$146.17M(-33.4%) |
| Mar 2011 | - | -$40.98M(-220.7%) | -$109.58M(-12.7%) |
| Dec 2010 | -$97.47M(-31.5%) | -$12.78M(+60.2%) | -$97.25M(+21.5%) |
| Sep 2010 | - | -$32.09M(-35.3%) | -$123.89M(-33.1%) |
| Jun 2010 | - | -$23.72M(+17.2%) | -$93.08M(-8.7%) |
| Mar 2010 | - | -$28.66M(+27.3%) | -$85.62M(-15.5%) |
| Dec 2009 | -$74.10M(+14.1%) | -$39.41M(-2952.5%) | -$74.10M(-6.9%) |
| Sep 2009 | - | -$1.29M(+92.1%) | -$69.29M(+21.2%) |
| Jun 2009 | - | -$16.27M(+5.1%) | -$87.93M(+3.4%) |
| Mar 2009 | - | -$17.14M(+50.5%) | -$91.06M(-1.4%) |
| Dec 2008 | -$86.25M(+24.6%) | -$34.60M(-73.6%) | -$89.83M(-34.5%) |
| Sep 2008 | - | -$19.93M(-2.8%) | -$66.77M(+21.9%) |
| Jun 2008 | - | -$19.39M(-21.9%) | -$85.50M(+11.6%) |
| Mar 2008 | - | -$15.91M(-37.9%) | -$96.72M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | -$114.45M(-6.3%) | -$11.53M(+70.2%) | -$114.45M(+16.1%) |
| Sep 2007 | - | -$38.67M(-26.3%) | -$136.40M(-8.2%) |
| Jun 2007 | - | -$30.60M(+9.0%) | -$126.02M(-5.5%) |
| Mar 2007 | - | -$33.65M(-0.5%) | -$119.47M(-11.3%) |
| Dec 2006 | -$107.66M(-186.5%) | -$33.48M(-18.3%) | -$107.31M(-6.1%) |
| Sep 2006 | - | -$28.30M(-17.7%) | -$101.14M(+5.7%) |
| Jun 2006 | - | -$24.05M(-11.9%) | -$107.24M(+7.0%) |
| Mar 2006 | - | -$21.49M(+21.3%) | -$115.36M(+5.6%) |
| Dec 2005 | $124.42M(+2103.7%) | -$27.31M(+20.6%) | -$122.21M(-34.4%) |
| Sep 2005 | - | -$34.39M(-6.9%) | -$90.92M(-37.7%) |
| Jun 2005 | - | -$32.17M(-13.5%) | -$66.01M(-42.0%) |
| Mar 2005 | - | -$28.34M(-813.1%) | -$46.49M(-923.4%) |
| Dec 2004 | $5.65M(+105.6%) | $3.97M(+141.9%) | $5.65M(+136.5%) |
| Sep 2004 | - | -$9.48M(+25.0%) | -$15.47M(+51.2%) |
| Jun 2004 | - | -$12.64M(-153.1%) | -$31.69M(+31.1%) |
| Mar 2004 | - | $23.79M(+238.8%) | -$45.98M(+53.2%) |
| Dec 2003 | -$99.99M(+18.0%) | -$17.14M(+33.3%) | -$98.15M(+15.1%) |
| Sep 2003 | - | -$25.70M(+4.6%) | -$115.67M(+6.1%) |
| Jun 2003 | - | -$26.93M(+5.1%) | -$123.15M(+2.4%) |
| Mar 2003 | - | -$28.38M(+18.1%) | -$126.17M(-2.6%) |
| Dec 2002 | -$121.95M(-42.3%) | -$34.66M(-4.5%) | -$122.98M(-4.3%) |
| Sep 2002 | - | -$33.18M(-10.8%) | -$117.91M(-9.1%) |
| Jun 2002 | - | -$29.95M(-18.9%) | -$108.03M(-12.3%) |
| Mar 2002 | - | -$25.19M(+14.9%) | -$96.17M(-12.2%) |
| Dec 2001 | -$85.68M(-239.0%) | -$29.59M(-27.0%) | -$85.68M(-52.8%) |
| Sep 2001 | - | -$23.29M(-28.8%) | -$56.09M(-33.6%) |
| Jun 2001 | - | -$18.09M(-22.9%) | -$41.98M(-50.6%) |
| Mar 2001 | - | -$14.71M(-60.2%) | -$27.87M(-22.5%) |
| Dec 2000 | -$25.28M(-6.2%) | - | - |
| Sep 2000 | - | -$9.18M(-131.0%) | -$22.76M(-23.5%) |
| Jun 2000 | - | -$3.98M(+44.9%) | -$18.43M(+17.0%) |
| Mar 2000 | - | -$7.21M(-201.5%) | -$22.20M(+5.0%) |
| Dec 1999 | -$23.80M(-90.4%) | -$2.39M(+50.7%) | -$23.36M(+24.1%) |
| Sep 1999 | - | -$4.85M(+37.4%) | -$30.80M(-13.1%) |
| Jun 1999 | - | -$7.75M(+7.4%) | -$27.24M(-56.1%) |
| Mar 1999 | - | -$8.37M(+14.8%) | -$17.45M(-36.4%) |
| Dec 1998 | -$12.50M(+8.8%) | -$9.82M(-659.9%) | -$12.79M(-60.6%) |
| Sep 1998 | - | -$1.29M(-163.6%) | -$7.97M(-2.5%) |
| Jun 1998 | - | $2.03M(+154.8%) | -$7.78M(+42.4%) |
| Mar 1998 | - | -$3.71M(+25.8%) | -$13.51M(+2.8%) |
| Dec 1997 | -$13.70M(+20.8%) | -$5.00M(-354.5%) | -$13.90M(-3.7%) |
| Sep 1997 | - | -$1.10M(+70.3%) | -$13.40M(+19.8%) |
| Jun 1997 | - | -$3.70M(+9.8%) | -$16.70M(0.0%) |
| Mar 1997 | - | -$4.10M(+8.9%) | -$16.70M(+3.5%) |
| Dec 1996 | -$17.30M(-127.6%) | -$4.50M(-2.3%) | -$17.30M(-11.6%) |
| Sep 1996 | - | -$4.40M(-18.9%) | -$15.50M(-14.8%) |
| Jun 1996 | - | -$3.70M(+21.3%) | -$13.50M(-21.6%) |
| Mar 1996 | - | -$4.70M(-74.1%) | -$11.10M(-30.6%) |
| Dec 1995 | -$7.60M(+74.0%) | -$2.70M(-12.5%) | -$8.50M(+22.0%) |
| Sep 1995 | - | -$2.40M(-84.6%) | -$10.90M(+10.7%) |
| Jun 1995 | - | -$1.30M(+38.1%) | -$12.20M(+41.6%) |
| Mar 1995 | - | -$2.10M(+58.8%) | -$20.90M(+28.4%) |
| Dec 1994 | -$29.20M(+24.7%) | -$5.10M(-37.8%) | -$29.20M(+17.3%) |
| Sep 1994 | - | -$3.70M(+63.0%) | -$35.30M(+13.7%) |
| Jun 1994 | - | -$10.00M(+3.8%) | -$40.90M(-0.5%) |
| Mar 1994 | - | -$10.40M(+7.1%) | -$40.70M(-3.0%) |
| Dec 1993 | -$38.80M(-112.0%) | -$11.20M(-20.4%) | -$39.50M(-14.8%) |
| Sep 1993 | - | -$9.30M(+5.1%) | -$34.40M(-12.1%) |
| Jun 1993 | - | -$9.80M(-6.5%) | -$30.70M(-25.8%) |
| Mar 1993 | - | -$9.20M(-50.8%) | -$24.40M(-32.6%) |
| Dec 1992 | -$18.30M(-90.6%) | -$6.10M(-8.9%) | -$18.40M(-15.0%) |
| Sep 1992 | - | -$5.60M(-60.0%) | -$16.00M(-24.0%) |
| Jun 1992 | - | -$3.50M(-9.4%) | -$12.90M(-13.2%) |
| Mar 1992 | - | -$3.20M(+13.5%) | -$11.40M(-83.9%) |
| Dec 1991 | -$9.60M(-190.9%) | -$3.70M(-48.0%) | -$6.20M(+34.7%) |
| Sep 1991 | - | -$2.50M(-25.0%) | -$9.50M(-66.7%) |
| Jun 1991 | - | -$2.00M(-200.0%) | -$5.70M(-128.0%) |
| Mar 1991 | - | $2.00M(+128.6%) | -$2.50M(+24.2%) |
| Dec 1990 | -$3.30M | -$7.00M(-638.5%) | -$3.30M(-189.2%) |
| Sep 1990 | - | $1.30M(+8.3%) | $3.70M(+54.2%) |
| Jun 1990 | - | $1.20M(0.0%) | $2.40M(+100.0%) |
| Mar 1990 | - | $1.20M | $1.20M |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual operating income?
- What is the all-time high annual operating profit for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual operating profit year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. TTM operating profit year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual operating income?
The current annual operating profit of REGN is $4.09B
What is the all-time high annual operating profit for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual operating income is $8.99B
What is Regeneron Pharmaceuticals, Inc. annual operating profit year-on-year change?
Over the past year, REGN annual operating income has changed by -$141.50M (-3.34%)
What is Regeneron Pharmaceuticals, Inc. quarterly operating income?
The current quarterly operating profit of REGN is $1.11B
What is the all-time high quarterly operating profit for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly operating income is $3.35B
What is Regeneron Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
Over the past year, REGN quarterly operating income has changed by -$125.80M (-10.18%)
What is Regeneron Pharmaceuticals, Inc. TTM operating income?
The current TTM operating profit of REGN is $3.83B
What is the all-time high TTM operating profit for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high TTM operating income is $9.12B
What is Regeneron Pharmaceuticals, Inc. TTM operating profit year-on-year change?
Over the past year, REGN TTM operating income has changed by -$308.40M (-7.45%)